Metropolitan Life Insurance Company (MetLife)’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-6,113
| Closed | -$24.5K | – | 2620 |
|
|
2020
Q1 | $24.5K | Sell |
6,113
-7,527
| -55% | -$30.1K | ﹤0.01% | 2430 |
|
|
2019
Q4 | $116K | Sell |
13,640
-300
| -2% | -$2.54K | ﹤0.01% | 2250 |
|
|
2019
Q3 | $95.5K | Buy |
13,940
+3,337
| +31% | +$22.9K | ﹤0.01% | 2326 |
|
|
2019
Q2 | $88.3K | Buy |
10,603
+956
| +10% | +$7.96K | ﹤0.01% | 2371 |
|
|
2019
Q1 | $88.5K | Hold |
9,647
| – | – | ﹤0.01% | 2387 |
|
|
2018
Q4 | $106K | Hold |
9,647
| – | – | ﹤0.01% | 2232 |
|
|
2018
Q3 | $135K | Hold |
9,647
| – | – | ﹤0.01% | 2273 |
|
|
2018
Q2 | $103K | Buy |
+9,647
| New | +$103K | ﹤0.01% | 2302 |
|
|
2014
Q3 | – | Sell |
-8,771
| Closed | -$163K | – | 2752 |
|
|
2014
Q2 | $163K | Buy |
+8,771
| New | +$163K | ﹤0.01% | 2626 |
|